Ostomy; Quality of life; Employment; Psychological; Veterans BACKGROUND: Intestinal stomas (ostomies) have been associated negatively with multiple aspects of health-related quality of life. This article examines the relationship between employment status and
Objectives Weight gain can cause retraction of an intestinal stoma, possibly resulting in difficulty with wafer and pouch fit, daily care challenges, and discomfort. This cross-sectional study examined the association between body mass index (BMI) and ostomy-related problems among long-term (>5 years post-diagnosis) colorectal cancer (CRC) survivors. Materials and Methods CRC survivors from three Kaiser Permanente Regions completed a mailed survey. The response rate for those with an ostomy was 53% (283/529). Questions included stoma-related problems and time to conduct daily ostomy care. Poisson regression evaluated associations between report of problems and change in BMI. Our analysis sample included 235 survivors. Results Sample was 76% ≥65 years of age. Since their surgeries, BMI remained stable in 44% (ST), decreased in 20% (DE), and increased in 35% (IN) of survivors. Compared to ST, male IN (RR 2.15 [1.09–4.25]) and female DE (RR 5.06 [1.26–25.0]) were more likely to spend more than 30 minutes per day on stoma care. IN (vs. ST) were more likely to report interference with clothing (RR 1.51 [1.06–2.17]) and other stoma-related problems (RR 2.32 [1.30–4.14]). Survivors who were obese at time of survey were more likely to report interference with clothing (RR 1.88 [1.38–2.56]) and other stoma-related problems (RR 1.68 [1.07–2.65]). Conclusion A change in BMI is associated with ostomy-related problems among long-term CRC survivors. Equipment and care practices may need to be adapted for changes in abdominal shape. Health care providers should caution that a significant increase or decrease in BMI may cause ostomy-related problems.
Background and Aims:Longer travel time to health care services has been shown to be associated with more advanced stage at diagnosis and differences in surgical care for women with breast cancer. The influence of travel time on other disease characteristics at diagnosis and on use of other breast cancer treatments is not known. We examined travel time in relation to stage, nodal involvement, tumor size, primary and adjuvant treatments, and receipt of surveillance mammography to provide a more detailed examination of the role of travel time in access and utilization of breast cancer services to help further understand barriers to recommended care. Methods: Using an established cohort of women enrolled at Group Health, with an early stage breast cancer diagnosis from 1990-1999 (N=1306), we linked travel time estimates with tumor and treatment data. Travel time was estimated for each census block in Washington to the nearest radiology facility and was then attributed to women based on geocoded residence data. Tumor and treatment data were abstracted from chart review and from SEER data. We modeled bivariate relations between travel time and outcomes using log binomial generalized linear regression (glm). Results: Most women (90%) lived within 30 minutes of the nearest radiology facility. Travel time >45 min. was associated with a greater likelihood of mastectomy vs. breast conserving surgery (Referent group:travel time <10min: RR=1.48; 95%CI:1.03-2.13) and with use of adjuvant chemotherapy (RR=1.65; 95% CI:1.01-2.70). Travel time did not significantly influence stage at diagnosis, tumor size, radiation treatment, or receipt of surveillance mammography in the first two years following cancer treatment. Conclusions: In the Group Health population, travel time appears to differentially influence patterns of care for women with early stage breast cancer and does not appear to be related to tumor characteristics at diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.